1. Home
  2. CGON vs LION Comparison

CGON vs LION Comparison

Compare CGON & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGON
  • LION
  • Stock Information
  • Founded
  • CGON 2010
  • LION 1997
  • Country
  • CGON United States
  • LION United States
  • Employees
  • CGON N/A
  • LION N/A
  • Industry
  • CGON
  • LION Movies/Entertainment
  • Sector
  • CGON
  • LION Consumer Discretionary
  • Exchange
  • CGON NYSE
  • LION Nasdaq
  • Market Cap
  • CGON 2.3B
  • LION 2.1B
  • IPO Year
  • CGON 2024
  • LION N/A
  • Fundamental
  • Price
  • CGON $29.08
  • LION $6.81
  • Analyst Decision
  • CGON Strong Buy
  • LION Strong Buy
  • Analyst Count
  • CGON 10
  • LION 3
  • Target Price
  • CGON $65.11
  • LION $11.33
  • AVG Volume (30 Days)
  • CGON 809.2K
  • LION 418.1K
  • Earning Date
  • CGON 02-02-2025
  • LION 02-06-2025
  • Dividend Yield
  • CGON N/A
  • LION N/A
  • EPS Growth
  • CGON N/A
  • LION N/A
  • EPS
  • CGON N/A
  • LION N/A
  • Revenue
  • CGON $684,000.00
  • LION $2,983,500,000.00
  • Revenue This Year
  • CGON $210.00
  • LION $5.75
  • Revenue Next Year
  • CGON N/A
  • LION $5.60
  • P/E Ratio
  • CGON N/A
  • LION N/A
  • Revenue Growth
  • CGON 258.12
  • LION N/A
  • 52 Week Low
  • CGON $25.77
  • LION $6.13
  • 52 Week High
  • CGON $50.23
  • LION $12.84
  • Technical
  • Relative Strength Index (RSI)
  • CGON 44.86
  • LION 40.10
  • Support Level
  • CGON $27.70
  • LION $6.92
  • Resistance Level
  • CGON $29.69
  • LION $7.24
  • Average True Range (ATR)
  • CGON 1.43
  • LION 0.33
  • MACD
  • CGON 0.16
  • LION -0.11
  • Stochastic Oscillator
  • CGON 31.29
  • LION 9.74

About CGON CG ONCOLOGY INC

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: